Avarieux
back to explore
Aardvark Therapeutics Inc logo

AARD

Aardvark Therapeutics Inc
NASDAQ NMS - GLOBAL MARKET· Pharmaceuticals· US· IPO 2025-02-13
$5.73
-0.22 (-3.70%)
last quote
Want the full multi-source brief on AARD?
The agent pulls regulatory filings, news flow, prediction-market pricing, and macro context — then synthesizes what's not yet in the price.
open in agent
Today
Open
$5.73
High
$6.19
Low
$5.60
Previous close
$5.95
Industry peers
by market cap
NRXP-0.87%RFL-1.59%NTHI-3.43%SMNR+0.00%RANI-0.70%CWEB.TOCPIX+3.53%CGTX+0.00%
Upcoming earnings
next 30 days
2026-11-11in 67 days
Q3 2026EPS est $-0.78
Recent SEC filings
CIK 1774857filing-language history →
42026-08-21reports 2026-08-14
5 KB
42026-08-21reports 2026-08-14
5 KB
42026-08-21reports 2026-08-14
5 KB
42026-08-21reports 2026-08-14
5 KB
8-K2026-08-17reports 2026-08-14
172 KB
10-Q2026-08-11reports 2026-06-30
7,079 KB
Recent news
2026-08-28 → 2026-09-04
Benzinga · 6d
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Aardvark Therapeutics (NASDAQ:AARD) shares increased by 8.5% to $6.28 during Friday's after-market session. The market value of their outstanding shares is at $144.8 million. TransCode Therapeutics
SEC EDGAR Yahoo Finance TradingView Company website
This is the free preview

The agent layer adds regulatory-language drift detection, cross-venue prediction-market signals, macro overlays, programmable alert rules, overnight briefs, and a grounding verifier on every claim. 7-day Pro trial, no card required.

Start the trial